1
Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A. C., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G. H., Peters, N. A. J. B., de Boer, M., Peer, P. G. M., Tjan-Heijnen, V. C. G.
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016
2
Pouwels, X. G. L. V., Geurts, S. M. E., Ramaekers, B. L. T., Erdkamp, F., Vriens, B. E. P. J., Aaldering, K. N. A., van de Wouw, A. J., Dercksen, M. W., Smilde, T. J., Peters, N. A. J. B., Riel, J. M. van, Pepels, M. J., Heijnen-Mommers, J., Joore, M. A., Tjan-Heijnen, V. C. G., de Boer, M.
Veröffentlicht in: Pouwels , X G L V , Geurts , S M E , Ramaekers , B L T , Erdkamp , F , Vriens , B E P J , Aaldering , K N A , van de Wouw , A J , Dercksen , M W , Smilde , T J , Peters , N A J B , Riel , J M V , Pepels , M J , Heijnen-Mommers , J , Joore , M A , Tjan-Heijnen , V C G & de Boer , M 2020 , ' The relative effectiveness of eribulin for advanced breast cancer treatment : a study of the southeast Netherlands advanced breast cancer registry ' , Acta Oncologica , vol. 59 , no. 1 , pp. 82-89 . https://doi.org/10.1080/0284186X.2019.1670356;
2020
Veröffentlicht in: Pouwels , X G L V , Geurts , S M E , Ramaekers , B L T , Erdkamp , F , Vriens , B E P J , Aaldering , K N A , van de Wouw , A J , Dercksen , M W , Smilde , T J , Peters , N A J B , Riel , J M V , Pepels , M J , Heijnen-Mommers , J , Joore , M A , Tjan-Heijnen , V C G & de Boer , M 2020 , ' The relative effectiveness of eribulin for advanced breast cancer treatment : a study of the southeast Netherlands advanced breast cancer registry ' , Acta Oncologica , vol. 59 , no. 1 , pp. 82-89 . https://doi.org/10.1080/0284186X.2019.1670356;
2020